This inventor holds 3 USPTO granted patents. Top assignee: New England Biolabs, Inc.. Active years: 1992-1993.
Location History:
- Reading, MA (US) (1992)
- Arlington, MA (US) (1993)
Company Filing History:
Years Active: 1992-1993
Title: The Innovations of Carol Polisson
Introduction
Carol Polisson is a notable inventor based in Reading, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of restriction endonucleases. With a total of 3 patents to her name, her work has had a profound impact on genetic research and molecular biology.
Latest Patents
Among her latest patents is a novel type II restriction endonuclease known as Apo I, which is obtainable from Arthrobacter protophormiae. This endonuclease recognizes specific nucleotide sequences and has a defined cleavage point, facilitating various genetic engineering applications. Another significant patent involves a restriction endonuclease derived from Kluyvera ascorbata, referred to as KasI. This invention further expands the toolkit available for researchers in the field.
Career Highlights
Carol Polisson is currently associated with New England Biolabs, Inc., a leading company in the biotechnology sector. Her work at this organization has allowed her to collaborate with other experts in the field and contribute to groundbreaking research.
Collaborations
Some of her notable coworkers include Derek Robinson and Keith D Lunnen. Their collaborative efforts have enhanced the research output and innovation at New England Biolabs, Inc.
Conclusion
Carol Polisson's contributions to biotechnology through her patents and collaborations highlight her role as a significant inventor in the field. Her work continues to influence genetic research and molecular biology advancements.